2,3-Dehydrosilybin B

2,3-Dehydrosilybin B
Product Name 2,3-Dehydrosilybin B
CAS No.: 142796-24-5
Catalog No.: CFN70271
Molecular Formula: C25H20O10
Molecular Weight: 480.4 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Targets: Amyloid β
Source: The herbs of Silybum marianum
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
2,3-Dehydrosilybin B inhibits Aβ aggregation.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Molecules.2022, 27(7):2116.
  • Antioxidants (Basel).2019, 8(8):E307
  • Evid Based Complement Alternat Med.2018, 2018:4259603
  • Int J Mol Sci.2022, 23(21):12816.
  • J Agric Food Chem.2015, 63(44):9869-78
  • Life Sci.2018, 209:498-506
  • Cancer Manag Res.2019, 11:483-500
  • Mol Biol Rep.2024, 51(1):117.
  • Journal of Molecular Liquids2022, 364:120062.
  • Biomedicines.2020, 8(11):486.
  • Silychristin B

    Catalog No: CFN95160
    CAS No: 879325-58-3
    Price: $318/5mg
    Isosilychristin

    Catalog No: CFN95369
    CAS No: 77182-66-2
    Price: $318/5mg
    2,3-Dehydrosilychristin

    Catalog No: CFN95370
    CAS No: 57499-41-9
    Price: $318/5mg
    Isosilybin

    Catalog No: CFN90260
    CAS No: 72581-71-6
    Price: $138/20mg
    Isosilybin A

    Catalog No: CFN91070
    CAS No: 142796-21-2
    Price: $218/5mg
    Isosilybin B

    Catalog No: CFN91071
    CAS No: 142796-22-3
    Price: $238/5mg
    Silymarin

    Catalog No: CFN99542
    CAS No: 22888-70-6
    Price: $30/20mg
    Silybin A

    Catalog No: CFN95149
    CAS No: 22888-70-6
    Price: $318/20mg
    Silybin B

    Catalog No: CFN92916
    CAS No: 142797-34-0
    Price: $368/20mg
    2,3-Dehydrosilybin A

    Catalog No: CFN70322
    CAS No: 25166-14-7
    Price: Inquiry(manager@chemfaces.com)
    ACS Chemical Neuroscience, 09 Jun 2017, 8(8):1767-1778.
    Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry.[Reference: WebLink]
    The self-assembling of the amyloid β (Aβ) peptide into neurotoxic aggregates is considered a central event in the pathogenesis of Alzheimer's disease (AD). Based on the "amyloid hypothesis", many efforts have been devoted to designing molecules able to halt disease progression by inhibiting Aβ self-assembly.
    METHODS AND RESULTS:
    Here, we combine biophysical (ThT assays, TEM and AFM imaging), biochemical (WB and ESI-MS), and computational (all-atom molecular dynamics) techniques to investigate the capacity of four optically pure components of the natural product silymarin (silybin A, silybin B, 2,3-dehydrosilybin A, 2,3-Dehydrosilybin B) to inhibit Aβ aggregation. Despite TEM analysis demonstrated that all the four investigated flavonoids prevent the formation of mature fibrils, ThT assays, WB and AFM investigations showed that only silybin B was able to halt the growth of small-sized protofibrils thus promoting the formation of large, amorphous aggregates. Molecular dynamics (MD) simulations indicated that silybin B interacts mainly with the C-terminal hydrophobic segment 35MVGGVV40 of Aβ40. Consequently to silybin B binding, the peptide conformation remains predominantly unstructured along all the simulations. By contrast, silybin A interacts preferentially with the segments 17LVFF20 and 27NKGAII32 of Aβ40 which shows a high tendency to form bend, turn, and β-sheet conformation in and around these two domains. Both 2,3-dehydrosilybin enantiomers bind preferentially the segment 17LVFF20 but lead to the formation of different small-sized, ThT-positive Aβ aggregates. Finally, in vivo studies in a transgenic Caenorhabditis elegans strain expressing human Aβ indicated that silybin B is the most effective of the four compounds in counteracting Aβ proteotoxicity.
    CONCLUSIONS:
    This study underscores the pivotal role of stereochemistry in determining the neuroprotective potential of silybins and points to silybin B as a promising lead compound for further development in anti-AD therapeutics.
    Tetrahedron Letters, 2013, 54(46):6279-6282.
    Microwave-assisted oxidation of silibinin: a simple and preparative method for the synthesis of improved radical scavengers.[Reference: WebLink]
    A new and preparative oxidation of silibinin has been developed to give access to two different silibinin derivatives known for their enhanced antioxidant properties.
    METHODS AND RESULTS:
    Conventional heating methods were compared with results obtained from microwave (MW) heating. The base-catalysed oxidation of silibinin under MW heating is a very efficient method for the preparation of 2,3-dehydrosilybin and a related silybin rearrangement product. This latter compound shows enhanced radical scavenging properties.
    CONCLUSIONS:
    Optimised conditions were used to prepare 2,3-dehydrosilybin A and 2,3-Dehydrosilybin B from optically pure silybin A and silybin B. An efficient, preparative purification method was also developed to enable isolation of different products in high purity.
    Carasinol D

    Catalog No: CFN95044
    CAS No: 1072797-66-0
    Price: $333/5mg
    Emodin-8-O-beta-gentiobioside

    Catalog No: CFN95132
    CAS No: 66466-22-6
    Price: $368/5mg
    Specioside B

    Catalog No: CFN95165
    CAS No: 126589-95-5
    Price: $368/5mg
    3-O-methylellagic acid 4'-O-alpha-L-rhamnopyranoside

    Catalog No: CFN95228
    CAS No: 51768-39-9
    Price: $413/5mg
    Batatasin IV

    Catalog No: CFN95319
    CAS No: 60347-67-3
    Price: $318/5mg
    Kaempferol 3,4'-di-O-glucoside

    Catalog No: CFN95357
    CAS No: 71939-16-7
    Price: $318/5mg
    Barbaloin-related compound B

    Catalog No: CFN95455
    CAS No: 473225-22-8
    Price: $318/5mg
    Gossypetin 3-sophoroside-8-glucoside

    Catalog No: CFN95528
    CAS No: 77306-93-5
    Price: $318/5mg
    (Z)-Ferulic acid 4-O-beta-D-glucoside

    Catalog No: CFN95546
    CAS No: 94942-20-8
    Price: $318/10mg
    Peltatoside 7-O-beta-glucopyranoside

    Catalog No: CFN95565
    CAS No: 813466-12-5
    Price: $318/20mg